Supply Chain Intelligence

Madrigal Pharmaceuticals, Inc. Supply Chain

MDGL supply chain intelligence for Madrigal Pharmaceuticals, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

MDGL ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

9Suppliers
9Customers
3Debt Items
20Related Chains

Madrigal Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
F-HOFFMANN-LA-ROCHE-LTD F-HOFFMANN-LA-ROCHE-LTD 90% Madrigal Pharmaceuticals, Inc. (the “Company”), F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (together, “Roche”) entered into the First Amendment
HOFFMANN-LA-ROCHE-INC HOFFMANN-LA-ROCHE-INC 90% Madrigal Pharmaceuticals, Inc. (the “Company”), F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (together, “Roche”) entered into the First Amendment
GYRE Gyre Therapeutics, Inc. 72% Reciprocal relationship from GYRE graph: associated with chronic liver disease (“CLD”) and chronic idiopathic thrombocytopenia (“ITP”). Other Product Candidates F573 is our clinical-stage product can…
IVA Inventiva S.A. 72% Reciprocal relationship from IVA graph: Reciprocal relationship from MDGL graph: hase 2 oral DGAT-2 inhibitor. DGAT-2 inhibitors work by blocking the final step in triglyceride assembly and storage, …
IVA Inventiva S.A. 72% hase 2 oral DGAT-2 inhibitor. DGAT-2 inhibitors work by blocking the final step in triglyceride assembly and storage, resulting in lower hepatic triglycerides, reduced lipotoxic fat and decreased inf…
NVO Novo Nordisk A/S 72% Reciprocal relationship from NVO graph: Reciprocal relationship from MDGL graph: Reciprocal relationship from NVO graph: Reciprocal relationship from MDGL graph: Reciprocal relationship from NVO grap…
NVO Novo Nordisk A/S 72% hase 2 oral DGAT-2 inhibitor. DGAT-2 inhibitors work by blocking the final step in triglyceride assembly and storage, resulting in lower hepatic triglycerides, reduced lipotoxic fat and decreased inf…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from MDGL graph: rice for supply of resmetirom is based on the volume of material subject to a purchase order. The initial term of th…
ORANY ORANY 72% rice for supply of resmetirom is based on the volume of material subject to a purchase order. The initial term of the Evonik Agreement will expire on December 31, 2029 and will be automatically renew…

Madrigal Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
IVA Inventiva S.A. 72% Reciprocal relationship from IVA graph: Reciprocal relationship from MDGL graph: Reciprocal relationship from IVA graph: Reciprocal relationship from MDGL graph: hase 2 oral DGAT-2 inhibitor. DGAT-2 …
IVA Inventiva S.A. 72% hase 2 oral DGAT-2 inhibitor. DGAT-2 inhibitors work by blocking the final step in triglyceride assembly and storage, resulting in lower hepatic triglycerides, reduced lipotoxic fat and decreased inf…
NVO Novo Nordisk A/S 72% Reciprocal relationship from NVO graph: Reciprocal relationship from MDGL graph: hase 2 oral DGAT-2 inhibitor. DGAT-2 inhibitors work by blocking the final step in triglyceride assembly and storage, …
NVO Novo Nordisk A/S 72% hase 2 oral DGAT-2 inhibitor. DGAT-2 inhibitors work by blocking the final step in triglyceride assembly and storage, resulting in lower hepatic triglycerides, reduced lipotoxic fat and decreased inf…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from MDGL graph: hase 2 oral DGAT-2 inhibitor. DGAT-2 inhibitors work by blocking the final step in triglyceride assembly and storage…
ORANY ORANY 72% hase 2 oral DGAT-2 inhibitor. DGAT-2 inhibitors work by blocking the final step in triglyceride assembly and storage, resulting in lower hepatic triglycerides, reduced lipotoxic fat and decreased inf…
VKTX Viking Therapeutics, Inc. 72% Reciprocal relationship from VKTX graph: Reciprocal relationship from MDGL graph: Reciprocal relationship from VKTX graph: y a given regulatory authority, such regulatory authority will determine tha…
CO-LLC-JEFFERIES-LLC CO-LLC-JEFFERIES-LLC 62% with changes in the prime rate. The First Amendment reduced the interest rate under the Amended Loan Facility to the greater of (i) the prime rate as reported in The Wall Street Journal plus 2.45% an…
COMPANY-LLC-EVERCORE-GROUP COMPANY-LLC-EVERCORE-GROUP 62% with changes in the prime rate. The First Amendment reduced the interest rate under the Amended Loan Facility to the greater of (i) the prime rate as reported in The Wall Street Journal plus 2.45% an…

Madrigal Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
MDGL-DEBT-10916 Xbrl Convertible 90% xbrl convertible detail from xbrl 2022-05-09.
MDGL-DEBT-10915 Warrants outstanding: 4555 90% xbrl warrant detail from xbrl 2023-12-31.
MDGL-DEBT Debt stack $347.3M 90% Market cache reports total debt of $347.3M.

Madrigal Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Madrigal Pharmaceuticals, Inc..

Madrigal Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
MDGL-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 384 tracked holders.

Madrigal Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ALEC Alector, Inc. 100.00 2
PHGE BiomX Inc. 100.00 2
ORANY ORANGE 100.00 1 ['customer', 'supplier']
GYRE Gyre Therapeutics, Inc. 100.00 1 ['supplier']
ENGN enGene Therapeutics Inc. 100.00 2
KURA Kura Oncology, Inc. 100.00 2
LGND Ligand Pharmaceuticals Incorporated 100.00 2
IRON Disc Medicine, Inc. 100.00 2
SVRA Savara Inc. 100.00 2
ALT Altimmune, Inc. 100.00 2
CMPS COMPASS Pathways plc 100.00 2
DB Deutsche Bank Aktiengesellschaft 100.00 2
IVA Inventiva S.A. 100.00 1 ['customer', 'supplier']
TGTX TG Therapeutics, Inc. 100.00 2
BCYC Bicycle Therapeutics plc 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
BBIO BridgeBio Pharma, Inc. 100.00 2
NVO Novo Nordisk A/S 100.00 1 ['customer', 'supplier']
SGHT Sight Sciences, Inc. 100.00 2
View MDGL supply chain intel →

Explore the full interactive supply chain map for Madrigal Pharmaceuticals, Inc..

Open MDGL supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map